ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Development and validation of four ferroptosis-related gene signatures and their correlations with immune implication in hepatocellular carcinoma

Zhang, Ying; Ren, He; Zhang, Chunting; Li, Haihua; Guo, Qingzhi; Xu, Haitao*; Cui, Lina*哈尔滨医科大学; 6
Frontiers in Immunology2022-10-11DOI: 10.3389/fimmu.2022.1028054
10被引14阅读
引用收藏
分享

摘要

Hepatocellular carcinoma (HCC) is one of the most common malignant tumors. This tumor presents with an insidious onset, rapid progression, and frequent recurrence. Ferroptosis is a newly discovered mode of programmed cell death that may play a key role in the progression of HCC. This study aimed to investigate the prognostic value of ferroptosis-related genes (FRGs) in HCC and their impact on tumor immune function, thereby providing new insights into targeted therapy for HCC. First, 43 differentially expressed FRGs were identified using the TCGA database, and four prognostically relevant methylation-driven FRGs (G6PD, HELLS, RRM2, and STMN1) were screened via survival and methylation analyses. Gene co-expression, mutation, and clinicopathological characterization indicated that these four pivotal FRGs play essential roles in tumor progression. We also validated these four genes using transcriptomic and proteomic data as well as cohort samples from our patients. Moreover, receiver operator characteristic (ROC) curves confirmed that the signatures of the four FRGs were independent prognostic factors in HCC. Gene set enrichment analysis of the four FRGs showed statistically significant associations with pathways related to HCC proliferation. Finally, the TIMER and TISIDB databases indicated that the four FRGs were statistically significantly correlated with tumor-infiltrating immune cells and immune checkpoint expression. Taken together, this study provides information guiding a novel therapeutic strategy targeting FRGs for HCC treatment.

学科与关键词

关键词
ferroptosishepatocellular carcinomaprognosistumor-infiltrating immune cellsimmune checkpoint
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Frontiers in Immunology
发表日期
2022-10-11
卷期
第 13 卷
页码
1028054
DOI
10.3389/fimmu.2022.1028054
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
Beijing Medical Award; Haiyan Fund of Harbin Medical University Cancer Hospital; [YXJL-2021-0268-0322]; [JJMS2021-22]; [JJQN2019-17]

作者

  • Z

    Zhang, Ying (第一作者)

    harbin med univ

  • R

    Ren, He

    harbin med univ · tianjin med univ · tianjin med univ gen hosp

查看全部 7 位作者收起作者
  • Z

    Zhang, Chunting

  • L

    Li, Haihua

  • G

    Guo, Qingzhi

    6 · heilongjiang acad tradit chinese med

  • X

    Xu, Haitao (通讯)

    harbin med univ

  • C

    Cui, Lina (通讯)

    harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417